Cameron Snell

3.0k total citations
44 papers, 1.9k citations indexed

About

Cameron Snell is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Cameron Snell has authored 44 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 19 papers in Molecular Biology and 14 papers in Cancer Research. Recurrent topics in Cameron Snell's work include HER2/EGFR in Cancer Research (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Cameron Snell is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Cameron Snell collaborates with scholars based in Australia, United Kingdom and Canada. Cameron Snell's co-authors include Adrian L. Harris, Helen Turley, Jiliang Li, Francesca M. Buffa, Alan McIntyre, Kevin C. Gatter, Helen Sheldon, Francesco Pezzella, Graham Steers and Harriet E. Gee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Cameron Snell

41 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cameron Snell Australia	18	1.3k	787	482	212	205	44	1.9k
Chirayu Goswami United States	25	1.1k 0.9×	572 0.7×	443 0.9×	161 0.8×	235 1.1×	44	1.8k
Esther Bridges United Kingdom	21	1.1k 0.9×	744 0.9×	430 0.9×	190 0.9×	130 0.6×	38	1.7k
Yi‐Mi Wu United States	10	1.9k 1.5×	1.2k 1.5×	361 0.7×	209 1.0×	297 1.4×	44	2.5k
Georgios Giamas United Kingdom	29	1.8k 1.4×	886 1.1×	724 1.5×	266 1.3×	276 1.3×	95	2.7k
Allie Fu United States	22	1.3k 1.0×	743 0.9×	462 1.0×	193 0.9×	263 1.3×	30	2.1k
Kakajan Komurov United States	23	1.7k 1.3×	603 0.8×	938 1.9×	294 1.4×	214 1.0×	44	2.5k
Pascal Jézéquel France	27	1.5k 1.1×	663 0.8×	789 1.6×	303 1.4×	430 2.1×	64	2.4k
Constadina Arvanitis United States	11	1.3k 1.0×	422 0.5×	637 1.3×	144 0.7×	139 0.7×	21	1.9k
Nicole M. Sodir United States	15	1.5k 1.2×	470 0.6×	889 1.8×	352 1.7×	143 0.7×	24	2.2k
Catherine Guérin‐Charbonnel France	19	1.7k 1.3×	569 0.7×	951 2.0×	175 0.8×	365 1.8×	48	2.4k

Countries citing papers authored by Cameron Snell

Since Specialization

Citations

This map shows the geographic impact of Cameron Snell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cameron Snell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cameron Snell more than expected).

Fields of papers citing papers by Cameron Snell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cameron Snell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cameron Snell. The network helps show where Cameron Snell may publish in the future.

Co-authorship network of co-authors of Cameron Snell

This figure shows the co-authorship network connecting the top 25 collaborators of Cameron Snell. A scholar is included among the top collaborators of Cameron Snell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cameron Snell. Cameron Snell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McEvoy, Christopher R., Catherine Mitchell, Owen W.J. Prall, et al.. (2025). The implementation of an RNA-based gene fusion assay into a diagnostic oncology department: an Australian perspective. Pathology. 57(5). 643–649.

Farshid, Gelareh, Jane E. Armes, Benjamin F. Dessauvagie, et al.. (2024). Independent Validation of a HER2-Low Focused Immunohistochemistry Scoring System for Enhanced Pathologist Precision and Consistency. Modern Pathology. 38(4). 100693–100693. 3 indexed citations

Huang, Xuan, Konstantin I. Momot, Tony Blick, et al.. (2023). Portable NMR for the investigation of models of mammographic density ex vivo: Androgens antagonise the promotional effect of oestrogen. 10(3-4). 77–97.

Ravichandran, Akhilandeshwari, James Monkman, Ahmed M. Mehdi, et al.. (2023). The in situ transcriptomic landscape of breast tumour-associated and normal adjacent endothelial cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(2). 166985–166985. 1 indexed citations

Liu, Cheng, Bhuvana Srinivasan, Louisa Dunk, et al.. (2023). Improved concordance of challenging human epidermal growth factor receptor 2 dual in‐situ hybridisation cases with the use of a digital image analysis algorithm in breast cancer. Histopathology. 83(4). 647–656. 4 indexed citations

Sheng, Yonghua, Cameron Snell, Nam‐Trung Nguyen, et al.. (2022). Isotypic analysis of anti-p53 serum autoantibodies and p53 protein tissue phenotypes in colorectal cancer. Human Pathology. 128. 1–10. 2 indexed citations

Lyons, Nicholas, Cameron Snell, Brian Wan-Chi Tse, et al.. (2022). CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapy. Theranostics. 12(16). 6915–6930. 6 indexed citations

Sheldon, Helen, Esther Bridges, Ildefonso Silva, et al.. (2021). ADGRL4/ELTD1 Expression in Breast Cancer Cells Induces Vascular Normalization and Immune Suppression. Molecular Cancer Research. 19(11). 1957–1969. 7 indexed citations

Keshvari, Sahar, Melanie Caruso, Lena Batoon, et al.. (2021). CSF1R-dependent macrophages control postnatal somatic growth and organ maturation. PLoS Genetics. 17(6). e1009605–e1009605. 49 indexed citations

10.

Cruz, Jazmina L. Gonzalez, Bijun Zeng, Muhammed B. Sabdia, et al.. (2021). Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression. Cancers. 13(15). 3733–3733. 13 indexed citations

11.

Patch, Ann‐Marie, Cameron Snell, Deborah S. Smith, et al.. (2020). FGFR2c Mesenchymal Isoform Expression Is Associated with Poor Prognosis and Further Refines Risk Stratification within Endometrial Cancer Molecular Subtypes. Clinical Cancer Research. 26(17). 4569–4580. 14 indexed citations

12.

Williams, Elizabeth D., Peter T. Simpson, Amy E. McCart Reed, et al.. (2020). Integrin alpha-2 and beta-1 expression increases through multiple generations of the EDW01 patient-derived xenograft model of breast cancer—insight into their role in epithelial mesenchymal transition in vivo gained from an in vitro model system. Breast Cancer Research. 22(1). 136–136. 14 indexed citations

13.

Snell, Cameron, Kristen Gibbons, Christopher Pyke, et al.. (2017). Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen. Journal of Clinical Pathology. 70(11). 954–960. 8 indexed citations

14.

Adams, Mark N., Joshua T. Burgess, Yaowu He, et al.. (2017). Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 12(7). 1071–1084. 63 indexed citations

15.

McIntyre, Alan, Alžbeta Hulı́ková, Ioanna Ledaki, et al.. (2016). Disrupting Hypoxia-Induced Bicarbonate Transport Acidifies Tumor Cells and Suppresses Tumor Growth. Cancer Research. 76(13). 3744–3755. 77 indexed citations

16.

Snell, Cameron, Helen Turley, JL Li, et al.. (2015). PAT4 levels control amino-acid sensitivity of rapamycin-resistant mTORC1 from the Golgi and affect clinical outcome in colorectal cancer. Oncogene. 35(23). 3004–3015. 50 indexed citations

17.

McIntyre, Alan, Shalini Patiar, Simon Wigfield, et al.. (2012). Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis In Vivo and Inhibition Enhances Anti-VEGF Therapy. Clinical Cancer Research. 18(11). 3100–3111. 188 indexed citations

18.

Buffa, Francesca M., Carlos Camps, Laura Winchester, et al.. (2011). microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer. Cancer Research. 71(17). 5635–5645. 251 indexed citations

19.

Li, Jiliang, Richard C.A. Sainson, Chern Ein Oon, et al.. (2011). DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy In Vivo. Cancer Research. 71(18). 6073–6083. 187 indexed citations

20.

Snell, Cameron, et al.. (2008). BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1tumour phenotype. Breast Cancer Research. 10(1). R12–R12. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact